Back to funds
View filing
Tetragon Partners GP Ltd
hedge fundUpdated 28 days agoManaged by Tfg Asset Management Gp Ltd • Latest filing Q2 2026
Portfolio value
$635.1M
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
96.7%
Weight of largest holdings
Annualized return
-11.7%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $747.5M |
| Q2 2023 | $740.6M |
| Q3 2023 | $548.3M |
| Q4 2023 | $415.3M |
| Q1 2024 | $441.5M |
| Q2 2024 | $400.9M |
| Q3 2024 | $354.5M |
| Q4 2024 | $405.6M |
| Q1 2025 | $438.2M |
| Q2 2025 | $620.8M |
| Q3 2025 | $747.6M |
| Q4 2025 | $474.3M |
| Q1 2026 | $515.1M |
| Q2 2026 | $635.1M |
Top holdings
43 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | P PATH UIPATH INC | $244M | 22.45M | 38.43% | — |
| 2 | P PATH UIPATH INC | $57.2M | 5.26M | 9.01% | — |
| 3 | P PATH UIPATH INC | $35.2M | 3.24M | 5.54% | — |
| 4 | K KGEI KOLIBRI GLOBAL ENERGY INC | $20.6M | 4.15M | 3.24% | — |
| 5 | A AUTL AUTOLUS THERAPEUTICS LTD | $15.2M | 9.50M | 2.39% | — |
| 6 | L LYFT LYFT INC | $14.6M | 1.00M | 2.30% | — |
| 7 | D DFTX DEFINIUM THERAPEUTICS INC | $13.5M | 287.0K | 2.13% | — |
| 8 | K KGEI KOLIBRI GLOBAL ENERGY INC | $13.3M | 2.68M | 2.09% | — |
| 9 | W WK WORKIVA INC | $12.1M | 250.0K | 1.91% | — |
| 10 | C CXM SPRINKLR INC | $11.4M | 2.20M | 1.79% | — |
| 11 | M MBX MBX BIOSCIENCES INC | $11.2M | 203.5K | 1.77% | — |
| 12 | A ALKT ALKAMI TECHNOLOGY INC | $10.9M | 600.3K | 1.71% | — |
| 13 | C CLDX CELLDEX THERAPEUTICS INC NEW | $10.8M | 290.4K | 1.70% | — |
| 14 | R RLAY RELAY THERAPEUTICS INC | $10.7M | 570.3K | 1.68% | — |
| 15 | A ARWR ARROWHEAD PHARMACEUTICALS IN | $10.6M | 130.5K | 1.67% | — |
| 16 | P PHVS PHARVARIS N V | $10.2M | 295.6K | 1.61% | — |
| 17 | A ALKS ALKERMES PLC | $10M | 190.0K | 1.57% | — |
| 18 | I IMVT IMMUNOVANT INC | $9.9M | 255.9K | 1.55% | — |
| 19 | A AXSM AXSOME THERAPEUTICS INC. | $8.6M | 35.0K | 1.35% | — |
| 20 | S SLNCF SILENCE THERAPEUTICS PLC | $8.4M | 764.3K | 1.32% | — |